When prostate cancer strikes, one question is paramount: Is it aggressive and requiring immediate treatment, or slow-growing and worthy of monitoring only? Right now, an invasive biopsy is the ...
A prostate cancer biomarker test that utilizes 17 genetic markers has demonstrated a high degree of accuracy in screening for serious cancer. The test also significantly reduced unnecessary ...
A new urine test could help men with an elevated PSA, or prostate specific antigen, level avoid unnecessary biopsies and MRIs ...
Researchers at the University of Michigan Health Rogel Cancer Center have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow growing form of ...
Prostate-specific antigen, or PSA, remains the linchpin of prostate cancer detection. MPS2 improves upon a urine-based test developed by the same U-M team nearly a decade ago, following a landmark ...
THURSDAY, April 18, 2024 (HealthDay News) -- When prostate cancer strikes, one question is paramount: Is it aggressive and requiring immediate treatment, or slow-growing and worthy of monitoring only?
A urine test which looks at 18 genes linked to aggressive prostate cancer could help men with the slow-growing form of the disease avoid unnecessary invasive biopsies, according to scientists.
When prostate cancer strikes, one question is paramount: Is it aggressive and requiring immediate treatment, or slow-growing and worthy of monitoring only? Right now, an invasive biopsy is the only ...